Clinical Trials Logo

Total Shoulder Arthoplasty clinical trials

View clinical trials related to Total Shoulder Arthoplasty.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT04827277 Enrolling by invitation - Clinical trials for Total Shoulder Arthoplasty

TSA Versus RSA in Patients >75

Start date: April 15, 2021
Phase: N/A
Study type: Interventional

Total shoulder arthroplasty (TSA) has proven to be a predictable and successful operation for the treatment of symptomatic glenohumeral osteoarthritis (GHOA) with an intact rotator cuff. Results after TSA have not been as good in cases with rotator cuff dysfunction, however. Early glenoid loosening, shoulder pain and the need for revision surgery has been all associated with rotator cuff deficiency. Even in cases without tears, fatty infiltration of the rotator cuff has been associated with inferior outcomes in TSA. Advanced age has been shown to be associated with increased fatty infiltration of the rotator cuff in shoulders with primary osteoarthritis. Because of this, one may propose that surgeons should avoid the potential complications with TSA and perform RSA for patients with advanced age. It is thus the purpose of this study to evaluate the patient reported outcomes (PROs) of total shoulder arthroplasty (TSA) compared with reverse shoulder arthroplasty (RSA) in patients >75 years of age